Long Jenny, Luckraz Heyman, Thekkudan Joyce, Maher Abdul, Norell Michael
Cardiothoracic Unit, Heart & Lung Centre, New Cross Hospital, Wolverhampton, UK.
Interact Cardiovasc Thorac Surg. 2012 May;14(5):594-8. doi: 10.1093/icvts/ivr157. Epub 2012 Jan 31.
Recent ESC/EACTS revascularization guidelines advocate a 'Heart Team' (HT) approach in the decision-making process when managing patients with coronary disease. We prospectively assessed HT decision-making in 150 patients analysing personnel attendance, data presented, the 'actioning' of the HT decision and, if not completed, then the reasons why. Additionally, 50 patients were specifically re-discussed after 1 year in order to assess consistency in decision-making. We have two HT meetings each week. At least one surgeon, interventional cardiologist and non-interventional cardiologist were present at all meetings. Data presented included patient demographics, symptoms, co-morbidities, coronary angiography, left ventricular function and other relevant investigations, e.g. echocardiograms. HT decisions included continued medical treatment (22%), percutaneous coronary intervention (PCI; 22%), coronary-artery bypass grafting (CABG; 34%) or further investigations such as pressure wire studies, dobutamine stress echo or cardiac magnetic resonance imaging (22%). These decisions were fully undertaken in 86% of patients. Reasons for aberration in the remaining 21 patients included patient refusal (CABG 29%, PCI 10%) and further co-morbidities (28%). On re-discussion of the same patient data (n = 50) a year later, 24% of decisions differed from the original HT recommendations reflecting the fact that, for certain coronary artery disease pattern, either CABG or PCI could be appropriate.
欧洲心脏病学会(ESC)/欧洲心胸外科学会(EACTS)近期发布的血运重建指南提倡在冠心病患者管理的决策过程中采用“心脏团队”(HT)模式。我们对150例患者的HT决策进行了前瞻性评估,分析了人员出勤情况、所呈现的数据、HT决策的“执行情况”,若未完成,则分析其原因。此外,为评估决策的一致性,我们在1年后对50例患者进行了专门的再次讨论。我们每周举行两次HT会议。每次会议至少有一名外科医生、介入心脏病专家和非介入心脏病专家出席。所呈现的数据包括患者人口统计学资料、症状、合并症、冠状动脉造影、左心室功能及其他相关检查,如超声心动图。HT的决策包括继续药物治疗(22%)、经皮冠状动脉介入治疗(PCI;22%)、冠状动脉旁路移植术(CABG;34%)或进一步检查,如压力导丝检查、多巴酚丁胺负荷超声心动图或心脏磁共振成像(22%)。这些决策在86%的患者中得到了充分执行。其余21例患者决策偏差的原因包括患者拒绝(CABG占29%,PCI占10%)和出现更多合并症(28%)。在1年后对相同患者数据(n = 50)进行再次讨论时,24%的决策与HT最初的建议不同,这反映出对于某些冠状动脉疾病模式,CABG或PCI可能都是合适的。